Wearable Injectors and Connected Devices Conference 2019

SMi is proud to present the inaugural Wearable Injectors and Connected Devices Conference, taking place on the 9th-10th October 2019, in London.

The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.

With this in mind, the conference will explore new technologies and advances of on-body devices for the administration of viscous and large molecule drug delivery, and evaluate the impact of IoT, connectivity and enhancement of user-interface, which make up core components within the wearable devices field.

BENEFITS OF ATTENDING:

LISTEN to case studies from leading pharmaceutical companies revolutionising the medical device industry
HEAR how on-body injectors are facilitating the administration of time-dependent, large volume and viscous drug delivery
ASSESS how connectivity is being used to improve patient adherence, health-monitoring and enhancing the user-interface
EXPLORE the compatibility, pain and patient handling considerations projecting wearable devices as the future of drug delivery

Join us in October 2019 to have the opportunity to network with Global Device Development Managers, Senior Connectivity Engineers, Leaders in Device Data Generation, Human Factors Directors and many more!

PLUS TWO INTERACTIVE PRE-CONFERENCE WORKSHOPS

Tuesday 8^th October 2019

Cross company collaboration to develop digital therapeutic solutions using connected devices

Workshop Leader: Digby Harris, Global Category Manager – Digital Therapeutics & Devices, AstraZeneca

Wearable injectors: Envisioning their evolution to address current and future unmet needs

Workshop Leader: James Blakemore, Senior Consultant, Cambridge Consultants

Workshop Leader: Sergio Marlorni, Senior Consultant, Cambridge Consultants

WHO SHOULD ATTEND?

Executives, Directors, VPs, Heads, Principals, Managers of: Drug-delivery developers, Autoinjectors, Device Engineering, Human Factor, Scientist, Product, Injectables, Packaging, Regulatory Affairs, Connectivity, Medical Device Data, Novel Product Technology, Smart device developers, Training device developers, Device-safety solution providers, Drug developers or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceutical, biotech and solution providers.

To register please visit: www.wearable-injectors.co.uk/pharmapwl

Early-Bird Rates